Review



rabbit polyclonal anti drd 1 antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bioss rabbit polyclonal anti drd 1 antibody
    Rabbit Polyclonal Anti Drd 1 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti drd 1 antibody/product/Bioss
    Average 94 stars, based on 6 article reviews
    rabbit polyclonal anti drd 1 antibody - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Bioss rabbit polyclonal anti drd 1 antibody
    Rabbit Polyclonal Anti Drd 1 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti drd 1 antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti drd 1 antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Bioss rabbit polyclonal anti drd1 antibody
    Rabbit Polyclonal Anti Drd1 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti drd1 antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti drd1 antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Bioss rabbit polyclonal anti drd1
    Western blots. A A typical Western blot for the D 1 receptor in hearts from WT, D 1 -TG, and D 1 -KO after incubation with the D 1 -dopamine receptor antibody is seen. The corresponding band for the D 1 receptor <t>(DRD1)</t> is labelled with an arrow. As loading control, the Ponceau S-stained membrane is shown below. B Typical Western blots for regulatory proteins in hearts from WT and D 1 -TG after incubation with the D 1 -dopamine receptor agonist SKF 38393 are seen. Western blots depict the phosphorylation state of inhibitory subunit of troponin (P-TnI) with arrows. As a loading control, we assessed the protein expression of cardiac calsequestrin (CSQ) by cutting horizontally the lanes of the blot and incubating the lower and upper halves with different primary antibodies. M rainbow marker, LA left atrium, RA right atrium, VT ventricle
    Rabbit Polyclonal Anti Drd1, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti drd1/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti drd1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal anti-dopamine receptor d1 (drd1
    HF, Hizikia fusiformis extract treatment; VEH, vehicle treatment (control); <t>DRD1-5,</t> dopamine <t>D1–5</t> receptors; DAT, dopamine transporter; DAPI, 4′,6-diamidino-2-phenylindole; NF-L, neurofilament light chain; SERT, serotonin transporter; TH, tyrosine hydroxylase; TPH, tryptophan hydroxylase; SYP, synaptophysin; 5HT1A and 1B, serotonin 1A and 1B receptors; MAP2, microtubule-associated protein 2.
    Rabbit Polyclonal Anti Dopamine Receptor D1 (Drd1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-dopamine receptor d1 (drd1/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-dopamine receptor d1 (drd1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    OriGene anti d1 dopamine receptor
    RNA sequencing data analysis in nax ( n = 5) and wild–type (wt) ( n = 6) mice. Data analysis shows dopamine receptor <t>D1</t> ( <t>Drd1,</t> A ), Drd3 ( C ), and Drd4 ( D ) are significantly increased in the nax cerebellum. Although an increase in Drd2 ( B ) and Drd5 ( E ) is apparent, statistical significance was not reached. The data in the bar graph are presented as the mean ± SEM, and statistical analysis was performed using an unpaired t –test (* p < 0.05 and ** p < 0.01). RPKM: Reads Per Kilobase of transcript per Million mapped reads.
    Anti D1 Dopamine Receptor, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti d1 dopamine receptor/product/OriGene
    Average 90 stars, based on 1 article reviews
    anti d1 dopamine receptor - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Millipore polyclonal rabbit anti-drd1
    Effects of siRNA on cell surface levels of <t>DRD2</t> in SH-SY5Y cells. A, Representative data from flow cytometric analysis of cell surface DRD2 expression. The overlaid histogram shows relative fluorescence intensities of DRD2 from 10,000 cells transfected with either random siRNA (black), DTNBP1 siRNA (green), or MUTED siRNA (pink). B, Changes in cell surface DRD2 expression by DTNBP1 siRNA or MUTED siRNA transfection. The geometric mean of the DRD2 fluorescence signal was obtained by flow cytometric analysis. Values are expressed as a percentage of random siRNA transfected cells. Error bars represent means ± SD (n = 3).
    Polyclonal Rabbit Anti Drd1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-drd1/product/Millipore
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-drd1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Western blots. A A typical Western blot for the D 1 receptor in hearts from WT, D 1 -TG, and D 1 -KO after incubation with the D 1 -dopamine receptor antibody is seen. The corresponding band for the D 1 receptor (DRD1) is labelled with an arrow. As loading control, the Ponceau S-stained membrane is shown below. B Typical Western blots for regulatory proteins in hearts from WT and D 1 -TG after incubation with the D 1 -dopamine receptor agonist SKF 38393 are seen. Western blots depict the phosphorylation state of inhibitory subunit of troponin (P-TnI) with arrows. As a loading control, we assessed the protein expression of cardiac calsequestrin (CSQ) by cutting horizontally the lanes of the blot and incubating the lower and upper halves with different primary antibodies. M rainbow marker, LA left atrium, RA right atrium, VT ventricle

    Journal: Naunyn-Schmiedeberg's Archives of Pharmacology

    Article Title: Initial characterization of a transgenic mouse with overexpression of the human D 1 -dopamine receptor in the heart

    doi: 10.1007/s00210-023-02901-y

    Figure Lengend Snippet: Western blots. A A typical Western blot for the D 1 receptor in hearts from WT, D 1 -TG, and D 1 -KO after incubation with the D 1 -dopamine receptor antibody is seen. The corresponding band for the D 1 receptor (DRD1) is labelled with an arrow. As loading control, the Ponceau S-stained membrane is shown below. B Typical Western blots for regulatory proteins in hearts from WT and D 1 -TG after incubation with the D 1 -dopamine receptor agonist SKF 38393 are seen. Western blots depict the phosphorylation state of inhibitory subunit of troponin (P-TnI) with arrows. As a loading control, we assessed the protein expression of cardiac calsequestrin (CSQ) by cutting horizontally the lanes of the blot and incubating the lower and upper halves with different primary antibodies. M rainbow marker, LA left atrium, RA right atrium, VT ventricle

    Article Snippet: First antibodies were rabbit polyclonal anti-calsequestrin (CSQ) antibody, #ab3516, Abcam, Cambridge, UK (diluted 1:20000), rabbit polyclonal anti-DRD1, #bs-1007R, Bioss, Woburn, MA, USA (dilution 1:500), and rabbit polyclonal anti-phospho-troponin I (P-TnI) antibody, #4004, Cell Signaling Technology Europe, Leiden, The Netherlands (diluted 1:5000).

    Techniques: Western Blot, Incubation, Control, Staining, Membrane, Expressing, Marker

    A Autoradiography. Representative images of autoradiography of D 1 -TG and WT mouse heart sections labeled with 5 nM [ 3 H]SCH23390 (total binding, TB) or 5 nM [ 3 H]SCH23390 + 10 M butaclamol (unspecific binding, UB). B In situ hybridization. Expression of D 1 -dopamine receptor mRNA detected by DIG-labelled human D 1 -dopamine receptor antisense probes (A-X) and DIG-labelled mouse D 1 -dopamine receptor antisense probes (a-l). DIG-labeled sense probes were used as controls. (A-H): Low magnification microscopic images, scale bar = 500 µm. mRNA expression of D 1 -dopamine receptor was not detected in WT mouse atria (A) and ventricles (C); whereas expression of human D 1 -dopamine receptor mRNA was detected in D 1 -Tg mouse atria (E) and ventricles including interventricular septum (G). (B, D, F, H) are corresponding control sections hybridized with DIG-labeled sense probes. (I-X): High magnification microscopic images, scale bar = 50 µm. No or very scarce and weak D 1 -dopamine mRNA expression was detected in WT mouse atria (I) and interventricular septum (K), while abundant human D 1 -dopamine mRNA expression was detected in atriums (M), interventricular septum (O), and ventricle walls (Q, S). (J, L, N, P, R, T) are corresponding control sections hybridized with DIG-labeled sense probes. D 1 -dopamine mRNA expression was also detected in human cardiomyocytes (U, W); while no signal was seen in corresponding control sections hybridized with DIG-labeled sense probes (V, X). (a-d): Low magnification microscopic images, scale bar = 500 µm. (e-h): High magnification microscopic images, scale bar = 50 µm. Expression of mouse D 1 -dopamine receptor mRNA was not detected in WT mouse atria (a, e) and ventricles (c, g); (b, d, f, h) are corresponding control sections hybridized with DIG-labeled sense probes. Low magnification images (i and j, scale bar = 500 µm) and high magnification images (k and l, scale bar = 50 µm) showed that the mouse antisense probe also detected human D 1 -dopamine mRNA expression in D 1 -TG mouse interventricular septum (i, k), while the mouse sense probe (control) did not detect any specific signal (j, l). C : Histology. Histological staining of myocardial sections with hematoxylin-eosin (HE) or Masson-Goldner trichome (MG) staining revealed no apparent abnormalities or signs of fibrosis, neither in WT nor in D 1 -TG. Scale bar = 100 µm. D : PCR. Scatter plots with means for the expression of exogenous transgenic D 1 -dopamine receptors (human-DRD1, left hand side) or endogenous mouse D 1 -dopamine receptors. Ordinates indicate the amount of the mRNA as inferred from the amplification cycles (Cq). *indicates significant differences between the mRNA from the whole heart of D 1 -TG versus WT

    Journal: Naunyn-Schmiedeberg's Archives of Pharmacology

    Article Title: Initial characterization of a transgenic mouse with overexpression of the human D 1 -dopamine receptor in the heart

    doi: 10.1007/s00210-023-02901-y

    Figure Lengend Snippet: A Autoradiography. Representative images of autoradiography of D 1 -TG and WT mouse heart sections labeled with 5 nM [ 3 H]SCH23390 (total binding, TB) or 5 nM [ 3 H]SCH23390 + 10 M butaclamol (unspecific binding, UB). B In situ hybridization. Expression of D 1 -dopamine receptor mRNA detected by DIG-labelled human D 1 -dopamine receptor antisense probes (A-X) and DIG-labelled mouse D 1 -dopamine receptor antisense probes (a-l). DIG-labeled sense probes were used as controls. (A-H): Low magnification microscopic images, scale bar = 500 µm. mRNA expression of D 1 -dopamine receptor was not detected in WT mouse atria (A) and ventricles (C); whereas expression of human D 1 -dopamine receptor mRNA was detected in D 1 -Tg mouse atria (E) and ventricles including interventricular septum (G). (B, D, F, H) are corresponding control sections hybridized with DIG-labeled sense probes. (I-X): High magnification microscopic images, scale bar = 50 µm. No or very scarce and weak D 1 -dopamine mRNA expression was detected in WT mouse atria (I) and interventricular septum (K), while abundant human D 1 -dopamine mRNA expression was detected in atriums (M), interventricular septum (O), and ventricle walls (Q, S). (J, L, N, P, R, T) are corresponding control sections hybridized with DIG-labeled sense probes. D 1 -dopamine mRNA expression was also detected in human cardiomyocytes (U, W); while no signal was seen in corresponding control sections hybridized with DIG-labeled sense probes (V, X). (a-d): Low magnification microscopic images, scale bar = 500 µm. (e-h): High magnification microscopic images, scale bar = 50 µm. Expression of mouse D 1 -dopamine receptor mRNA was not detected in WT mouse atria (a, e) and ventricles (c, g); (b, d, f, h) are corresponding control sections hybridized with DIG-labeled sense probes. Low magnification images (i and j, scale bar = 500 µm) and high magnification images (k and l, scale bar = 50 µm) showed that the mouse antisense probe also detected human D 1 -dopamine mRNA expression in D 1 -TG mouse interventricular septum (i, k), while the mouse sense probe (control) did not detect any specific signal (j, l). C : Histology. Histological staining of myocardial sections with hematoxylin-eosin (HE) or Masson-Goldner trichome (MG) staining revealed no apparent abnormalities or signs of fibrosis, neither in WT nor in D 1 -TG. Scale bar = 100 µm. D : PCR. Scatter plots with means for the expression of exogenous transgenic D 1 -dopamine receptors (human-DRD1, left hand side) or endogenous mouse D 1 -dopamine receptors. Ordinates indicate the amount of the mRNA as inferred from the amplification cycles (Cq). *indicates significant differences between the mRNA from the whole heart of D 1 -TG versus WT

    Article Snippet: First antibodies were rabbit polyclonal anti-calsequestrin (CSQ) antibody, #ab3516, Abcam, Cambridge, UK (diluted 1:20000), rabbit polyclonal anti-DRD1, #bs-1007R, Bioss, Woburn, MA, USA (dilution 1:500), and rabbit polyclonal anti-phospho-troponin I (P-TnI) antibody, #4004, Cell Signaling Technology Europe, Leiden, The Netherlands (diluted 1:5000).

    Techniques: Autoradiography, Labeling, Binding Assay, In Situ Hybridization, Expressing, Control, Staining, Transgenic Assay, Amplification

    HF, Hizikia fusiformis extract treatment; VEH, vehicle treatment (control); DRD1-5, dopamine D1–5 receptors; DAT, dopamine transporter; DAPI, 4′,6-diamidino-2-phenylindole; NF-L, neurofilament light chain; SERT, serotonin transporter; TH, tyrosine hydroxylase; TPH, tryptophan hydroxylase; SYP, synaptophysin; 5HT1A and 1B, serotonin 1A and 1B receptors; MAP2, microtubule-associated protein 2.

    Journal: Nutrition Research and Practice

    Article Title: Dopamine and serotonin alterations by Hizikia fusiformis extracts under in vitro cortical primary neuronal cell cultures

    doi: 10.4162/nrp.2023.17.3.408

    Figure Lengend Snippet: HF, Hizikia fusiformis extract treatment; VEH, vehicle treatment (control); DRD1-5, dopamine D1–5 receptors; DAT, dopamine transporter; DAPI, 4′,6-diamidino-2-phenylindole; NF-L, neurofilament light chain; SERT, serotonin transporter; TH, tyrosine hydroxylase; TPH, tryptophan hydroxylase; SYP, synaptophysin; 5HT1A and 1B, serotonin 1A and 1B receptors; MAP2, microtubule-associated protein 2.

    Article Snippet: In this study, we used primary antibodies for DA transmission: mouse monoclonal anti-tyrosine hydroxylase (TH; Abcam; catalog #ab129991), rabbit polyclonal anti-DAT (Santa Cruz; catalog #sc-14002), rabbit polyclonal anti-dopamine receptor D1 (DRD1; Santa Cruz; catalog #sc-14001), mouse monoclonal anti-DRD2 (Santa Cruz; catalog #sc-5303), mouse monoclonal anti-DRD3 (Santa Cruz; catalog #sc-136170), rabbit polyclonal anti-DRD4 (Elabscience; catalog #E-AB-31153), and rabbit polyclonal anti-DRD5 (Mybiosource; catalog #MBS2516950) antibodies; those for 5-HT transmission: rabbit polyclonal anti-5HT1A (Elabscience; catalog #E-AB-32950), rabbit polyclonal anti-5HT1B (Abcam; catalog #ab13896), anti-tryptophan hydroxylase (TPH; catalog #E-AB-16937), and mouse monoclonal anti-SERT (Santa Cruz; catalog #sc-33724) antibodies; and those for neuronal structures: mouse monoclonal anti-synaptophysin (SYP; Sigma-Aldrich; catalog #S5768), mouse monoclonal anti-microtubule-associated protein 2 (MAP2; Santa Cruz; catalog #sc-32791), and mouse monoclonal neurofilament-light chain (NF-L; Santa Cruz; catalog #sc-20012) antibodies.

    Techniques:

    DRD1–5, dopamine D1–5 receptors; HF, Hizikia fusiformis extract treatment; VEH, vehicle treatment (control); DAT, dopamine transporter; TH, tyrosine hydroxylase.

    Journal: Nutrition Research and Practice

    Article Title: Dopamine and serotonin alterations by Hizikia fusiformis extracts under in vitro cortical primary neuronal cell cultures

    doi: 10.4162/nrp.2023.17.3.408

    Figure Lengend Snippet: DRD1–5, dopamine D1–5 receptors; HF, Hizikia fusiformis extract treatment; VEH, vehicle treatment (control); DAT, dopamine transporter; TH, tyrosine hydroxylase.

    Article Snippet: In this study, we used primary antibodies for DA transmission: mouse monoclonal anti-tyrosine hydroxylase (TH; Abcam; catalog #ab129991), rabbit polyclonal anti-DAT (Santa Cruz; catalog #sc-14002), rabbit polyclonal anti-dopamine receptor D1 (DRD1; Santa Cruz; catalog #sc-14001), mouse monoclonal anti-DRD2 (Santa Cruz; catalog #sc-5303), mouse monoclonal anti-DRD3 (Santa Cruz; catalog #sc-136170), rabbit polyclonal anti-DRD4 (Elabscience; catalog #E-AB-31153), and rabbit polyclonal anti-DRD5 (Mybiosource; catalog #MBS2516950) antibodies; those for 5-HT transmission: rabbit polyclonal anti-5HT1A (Elabscience; catalog #E-AB-32950), rabbit polyclonal anti-5HT1B (Abcam; catalog #ab13896), anti-tryptophan hydroxylase (TPH; catalog #E-AB-16937), and mouse monoclonal anti-SERT (Santa Cruz; catalog #sc-33724) antibodies; and those for neuronal structures: mouse monoclonal anti-synaptophysin (SYP; Sigma-Aldrich; catalog #S5768), mouse monoclonal anti-microtubule-associated protein 2 (MAP2; Santa Cruz; catalog #sc-32791), and mouse monoclonal neurofilament-light chain (NF-L; Santa Cruz; catalog #sc-20012) antibodies.

    Techniques:

    A summary of BF 10 with post-hoc pair wise comparisons

    Journal: Nutrition Research and Practice

    Article Title: Dopamine and serotonin alterations by Hizikia fusiformis extracts under in vitro cortical primary neuronal cell cultures

    doi: 10.4162/nrp.2023.17.3.408

    Figure Lengend Snippet: A summary of BF 10 with post-hoc pair wise comparisons

    Article Snippet: In this study, we used primary antibodies for DA transmission: mouse monoclonal anti-tyrosine hydroxylase (TH; Abcam; catalog #ab129991), rabbit polyclonal anti-DAT (Santa Cruz; catalog #sc-14002), rabbit polyclonal anti-dopamine receptor D1 (DRD1; Santa Cruz; catalog #sc-14001), mouse monoclonal anti-DRD2 (Santa Cruz; catalog #sc-5303), mouse monoclonal anti-DRD3 (Santa Cruz; catalog #sc-136170), rabbit polyclonal anti-DRD4 (Elabscience; catalog #E-AB-31153), and rabbit polyclonal anti-DRD5 (Mybiosource; catalog #MBS2516950) antibodies; those for 5-HT transmission: rabbit polyclonal anti-5HT1A (Elabscience; catalog #E-AB-32950), rabbit polyclonal anti-5HT1B (Abcam; catalog #ab13896), anti-tryptophan hydroxylase (TPH; catalog #E-AB-16937), and mouse monoclonal anti-SERT (Santa Cruz; catalog #sc-33724) antibodies; and those for neuronal structures: mouse monoclonal anti-synaptophysin (SYP; Sigma-Aldrich; catalog #S5768), mouse monoclonal anti-microtubule-associated protein 2 (MAP2; Santa Cruz; catalog #sc-32791), and mouse monoclonal neurofilament-light chain (NF-L; Santa Cruz; catalog #sc-20012) antibodies.

    Techniques:

    RNA sequencing data analysis in nax ( n = 5) and wild–type (wt) ( n = 6) mice. Data analysis shows dopamine receptor D1 ( Drd1, A ), Drd3 ( C ), and Drd4 ( D ) are significantly increased in the nax cerebellum. Although an increase in Drd2 ( B ) and Drd5 ( E ) is apparent, statistical significance was not reached. The data in the bar graph are presented as the mean ± SEM, and statistical analysis was performed using an unpaired t –test (* p < 0.05 and ** p < 0.01). RPKM: Reads Per Kilobase of transcript per Million mapped reads.

    Journal: International Journal of Molecular Sciences

    Article Title: Alteration of the Dopamine Receptors’ Expression in the Cerebellum of the Lysosomal Acid Phosphatase 2 Mutant (Naked–Ataxia ( NAX )) Mouse

    doi: 10.3390/ijms21082914

    Figure Lengend Snippet: RNA sequencing data analysis in nax ( n = 5) and wild–type (wt) ( n = 6) mice. Data analysis shows dopamine receptor D1 ( Drd1, A ), Drd3 ( C ), and Drd4 ( D ) are significantly increased in the nax cerebellum. Although an increase in Drd2 ( B ) and Drd5 ( E ) is apparent, statistical significance was not reached. The data in the bar graph are presented as the mean ± SEM, and statistical analysis was performed using an unpaired t –test (* p < 0.05 and ** p < 0.01). RPKM: Reads Per Kilobase of transcript per Million mapped reads.

    Article Snippet: D1: rabbit polyclonal anti–D1 dopamine receptor (TA328798, anti–Drd1, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA); D2: rabbit polyclonal anti–D2 dopamine receptor (TA328800, anti–Drd2, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor 2 (DR2); D3: rabbit polyclonal anti–D3 dopamine receptor (TA328800, anti–Drd3, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor 3 (DR3); D4: rabbit polyclonal anti–D4 dopamine receptor (TA321202, anti–DRD4, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor D4 (DRD4); and D5: rabbit polyclonal anti–D5 dopamine receptor (TA328802, anti–Drd5, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor 5 (DR5).

    Techniques: RNA Sequencing Assay

    Frontal sections of wt and nax mouse cerebella: DRD1 expression at P5 and P17. ( A ) Immunoperoxidase staining for DRD1 in the wt cerebellum on P5 shows the immunoreactivity in the Purkinje cell layer (Pcl) and white matter (wm) but not in the external germinal zone (egz) and granular layer (gl). ( B ) Immunoperoxidase staining for DRD1 in the nax cerebellum shows similar immunoreactivity as in the wt littermates at P5. ( C ) DRD1 immunostaining of the frontal sections of the wt cerebellum at P17 shows immunoreactivity in the Purkinje cell (PC) somata, the Pcl, and dendrites in the molecular layer (ml) and in the gl but not in the wm. ( D ) DRD1 immunostaining of the frontal sections of the nax cerebellum on P17 shows immunoreactivity in the PCs in the ml/Pcl. ( E ) Western blot analysis of whole cerebellar lysates revealed no significant differences in DRD1 expression between wt and nax cerebella at P5 and P17 (wt: n = 3 and nax : n = 3). The data in the bar graphs are presented as the means of three independent experiments ± SEM, and statistical analysis was performed using a two–way ANOVA. P; postnatal. Scale bars: 100 μm in A, B, C, and D.

    Journal: International Journal of Molecular Sciences

    Article Title: Alteration of the Dopamine Receptors’ Expression in the Cerebellum of the Lysosomal Acid Phosphatase 2 Mutant (Naked–Ataxia ( NAX )) Mouse

    doi: 10.3390/ijms21082914

    Figure Lengend Snippet: Frontal sections of wt and nax mouse cerebella: DRD1 expression at P5 and P17. ( A ) Immunoperoxidase staining for DRD1 in the wt cerebellum on P5 shows the immunoreactivity in the Purkinje cell layer (Pcl) and white matter (wm) but not in the external germinal zone (egz) and granular layer (gl). ( B ) Immunoperoxidase staining for DRD1 in the nax cerebellum shows similar immunoreactivity as in the wt littermates at P5. ( C ) DRD1 immunostaining of the frontal sections of the wt cerebellum at P17 shows immunoreactivity in the Purkinje cell (PC) somata, the Pcl, and dendrites in the molecular layer (ml) and in the gl but not in the wm. ( D ) DRD1 immunostaining of the frontal sections of the nax cerebellum on P17 shows immunoreactivity in the PCs in the ml/Pcl. ( E ) Western blot analysis of whole cerebellar lysates revealed no significant differences in DRD1 expression between wt and nax cerebella at P5 and P17 (wt: n = 3 and nax : n = 3). The data in the bar graphs are presented as the means of three independent experiments ± SEM, and statistical analysis was performed using a two–way ANOVA. P; postnatal. Scale bars: 100 μm in A, B, C, and D.

    Article Snippet: D1: rabbit polyclonal anti–D1 dopamine receptor (TA328798, anti–Drd1, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA); D2: rabbit polyclonal anti–D2 dopamine receptor (TA328800, anti–Drd2, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor 2 (DR2); D3: rabbit polyclonal anti–D3 dopamine receptor (TA328800, anti–Drd3, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor 3 (DR3); D4: rabbit polyclonal anti–D4 dopamine receptor (TA321202, anti–DRD4, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor D4 (DRD4); and D5: rabbit polyclonal anti–D5 dopamine receptor (TA328802, anti–Drd5, diluted 1:1000; OriGene Biotech Co., Rockville, MD, USA), produced against recombinant rat dopamine receptor 5 (DR5).

    Techniques: Expressing, Immunoperoxidase Staining, Immunostaining, Western Blot

    Effects of siRNA on cell surface levels of DRD2 in SH-SY5Y cells. A, Representative data from flow cytometric analysis of cell surface DRD2 expression. The overlaid histogram shows relative fluorescence intensities of DRD2 from 10,000 cells transfected with either random siRNA (black), DTNBP1 siRNA (green), or MUTED siRNA (pink). B, Changes in cell surface DRD2 expression by DTNBP1 siRNA or MUTED siRNA transfection. The geometric mean of the DRD2 fluorescence signal was obtained by flow cytometric analysis. Values are expressed as a percentage of random siRNA transfected cells. Error bars represent means ± SD (n = 3).

    Journal: The Journal of Neuroscience

    Article Title: Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D 2 Receptor Internalization and Signaling But Not D 1 Internalization

    doi: 10.1523/JNEUROSCI.1689-07.2007

    Figure Lengend Snippet: Effects of siRNA on cell surface levels of DRD2 in SH-SY5Y cells. A, Representative data from flow cytometric analysis of cell surface DRD2 expression. The overlaid histogram shows relative fluorescence intensities of DRD2 from 10,000 cells transfected with either random siRNA (black), DTNBP1 siRNA (green), or MUTED siRNA (pink). B, Changes in cell surface DRD2 expression by DTNBP1 siRNA or MUTED siRNA transfection. The geometric mean of the DRD2 fluorescence signal was obtained by flow cytometric analysis. Values are expressed as a percentage of random siRNA transfected cells. Error bars represent means ± SD (n = 3).

    Article Snippet: Polyclonal rabbit anti-DRD2 and anti-DRD1 were obtained from Millipore (Temecula, CA) and monoclonal PE-conjugated anti-cAMP response element-binding protein (CREB) (pS133) was from BD Biosciences (Palo Alto, CA).

    Techniques: Expressing, Fluorescence, Transfection

    Effects of dopamine stimulation on cell surface DRD1 or DRD2 levels in siRNA transfected rat primary neurons. The geometric mean of cell surface of DRD1 or DRD2 fluorescence was obtained by flow cytometric analysis. Values are expressed as a percentage of random siRNA transfected cells. Error bars represent means ± SD (n = 4).

    Journal: The Journal of Neuroscience

    Article Title: Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D 2 Receptor Internalization and Signaling But Not D 1 Internalization

    doi: 10.1523/JNEUROSCI.1689-07.2007

    Figure Lengend Snippet: Effects of dopamine stimulation on cell surface DRD1 or DRD2 levels in siRNA transfected rat primary neurons. The geometric mean of cell surface of DRD1 or DRD2 fluorescence was obtained by flow cytometric analysis. Values are expressed as a percentage of random siRNA transfected cells. Error bars represent means ± SD (n = 4).

    Article Snippet: Polyclonal rabbit anti-DRD2 and anti-DRD1 were obtained from Millipore (Temecula, CA) and monoclonal PE-conjugated anti-cAMP response element-binding protein (CREB) (pS133) was from BD Biosciences (Palo Alto, CA).

    Techniques: Transfection, Fluorescence

    Effects of dopamine stimulation on cell surface levels of DRD2 in DTNBP1 siRNA transfected SH-SY5Y cells. A, Representative data from flow cytometric analysis of cell surface DRD2. The overlaid histogram shows relative fluorescence intensities of DRD2 from cells treated with random siRNA (black), random siRNA plus dopamine (DA; green), DTNBP1 siRNA (pink), or DTNBP1 siRNA plus DA (blue). B, Dopamine-induced changes in cell surface DRD2 expression. The geometric mean of cell surface of DRD2 fluorescence was obtained by flow cytometric analysis. Values are expressed as a percentage of random siRNA transfected cells. Error bars represent means ± SD (n = 4). C–E, Representative confocal images of DRD2 expression in SH-SY5Y cells transfected with random siRNA (C, D) or DTNBP1 siRNA (E, F). C, E, Not treated. D, F, Treated with 10 μm DA for 30 min. Scale bar, 10 μm.

    Journal: The Journal of Neuroscience

    Article Title: Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D 2 Receptor Internalization and Signaling But Not D 1 Internalization

    doi: 10.1523/JNEUROSCI.1689-07.2007

    Figure Lengend Snippet: Effects of dopamine stimulation on cell surface levels of DRD2 in DTNBP1 siRNA transfected SH-SY5Y cells. A, Representative data from flow cytometric analysis of cell surface DRD2. The overlaid histogram shows relative fluorescence intensities of DRD2 from cells treated with random siRNA (black), random siRNA plus dopamine (DA; green), DTNBP1 siRNA (pink), or DTNBP1 siRNA plus DA (blue). B, Dopamine-induced changes in cell surface DRD2 expression. The geometric mean of cell surface of DRD2 fluorescence was obtained by flow cytometric analysis. Values are expressed as a percentage of random siRNA transfected cells. Error bars represent means ± SD (n = 4). C–E, Representative confocal images of DRD2 expression in SH-SY5Y cells transfected with random siRNA (C, D) or DTNBP1 siRNA (E, F). C, E, Not treated. D, F, Treated with 10 μm DA for 30 min. Scale bar, 10 μm.

    Article Snippet: Polyclonal rabbit anti-DRD2 and anti-DRD1 were obtained from Millipore (Temecula, CA) and monoclonal PE-conjugated anti-cAMP response element-binding protein (CREB) (pS133) was from BD Biosciences (Palo Alto, CA).

    Techniques: Transfection, Fluorescence, Expressing